RAAS Fact Checking Module 3

RAAS Fact Checking Module 3

General PracticeFamily MedicineInternal MedicineCardiologyEndocrinology
A badge with ribbon in color black CPD Unit: 1 Point | An analog clock in color black 36 Minutes  | A black calendar with white triangle in center that has a black exclamation point in the middle 22 Jul 2025 

Overview

About this course

This video on demand lecture will discuss vascular protection in hypertension and renal disease.

This course explores the role of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARBs) in managing hypertension, slowing kidney disease progression, and providing vascular protection. It examines their effects on proteinuria, endothelial function, and cardiovascular outcomes, particularly in high-risk patients. This will also review the similarities and differences between ACEi and ARBs, guiding their efficient use in patient care.

Learning outcomes

Upon module completion, participant will be able to:
  • Contrast the evidence for angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) in reducing proteinuria levels in patients with CKD.
  • Evaluate the evidence for ACEi and ARBs in the prevention of CKD in diabetic patients with high cardiovascular risk.
  • Differentiate the effects of ACEi and ARBs on endothelial function.
  • Evaluate the evidence for ACEi and ARBs in reducing all-cause and cardiovascular mortality in high-risk patients
Topics Covered
Hypertension in special population: Renal disease
Beyond blood pressure - focus on vascular protection

Speaker

speaker_anthony_russel_villanueva.png

ANTHONY RUSSELL T. VILLANUEVA, MD, FPCP, FPSN
Adult Nephrologist
Medical Specialist, National Kidney Transplant Institute

1 CPD Point Available

  • Score at least 80% on the quiz.
  • A certificate can be downloaded upon successful completion. Please use the information on the certificate to claim your CPD points.

Sponsored by

Servier logo.jpg

Something went wrong.